Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438940 · ClinicalTrials.gov registry record · NA
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
A NA study of GastroEsophageal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05438940 is a NA study of GastroEsophageal Cancer that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 23 participants, below the 496-participant average among 23 other GastroEsophageal Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05438940, a NA study of GastroEsophageal Cancer, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation treatment
Conditions Studied
Interventions
- BEHAVIORAL Fitbit Data Collection
- BEHAVIORAL Nutrition Counseling
- BEHAVIORAL Survey
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438940
The ClinicalTrials.gov registry entry for NCT05438940 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 496-participant average among 23 other GastroEsophageal Cancer trials with a reported enrollment target (95% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with GastroEsophageal Cancer appearing as the primary indexed condition, and to 3 interventions - of which Fitbit Data Collection is the first listed.
NCT05438940 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05438940 about?
NCT05438940 is a clinical study titled "Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients". The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation...
What is the current status of trial NCT05438940?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2022-07-15. Estimated completion is 2026-06.
What conditions does trial NCT05438940 study?
This clinical trial studies the following conditions: GastroEsophageal Cancer.
What interventions are being tested in trial NCT05438940?
The interventions under investigation include: Fitbit Data Collection (BEHAVIORAL), Nutrition Counseling (BEHAVIORAL), Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT05438940?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438940 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GastroEsophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
RECRUITING · NA
-
Supportive Oncology Care At Home RCT
ACTIVE NOT RECRUITING · NA
-
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
RECRUITING · Phase 2
-
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
RECRUITING · Phase 2
-
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.